Pierre Bories
- Hematology top 5%
- Multiple Myeloma Research and Treatments 15
- Acute Myeloid Leukemia Research 14
- Nephrology top 5%
-
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
-
- CAR-T cell therapy research 9
- Peptidase Inhibition and Analysis 6
-
- Protein Degradation and Inhibitors 7
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- Marie‐Pierre LedouxRaoul HerbrechtValérie Letscher‐BruD. DurandChristian RécherLionel RostaingSarah BertoliNassim Kamar
- Cited by
- HematologyNephrologyGenetics
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Pierre Bories
52 papers receiving 630 citations
Peers
Comparison fields: 5 of 85
- Hematology 193
- Nephrology 99
- Genetics 72
- Oncology 152
- Infectious Diseases 102
Countries citing papers authored by Pierre Bories
This map shows the geographic impact of Pierre Bories's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bories with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bories more than expected).
Fields of papers citing papers by Pierre Bories
This network shows the impact of papers produced by Pierre Bories. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bories. The network helps show where Pierre Bories may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierre Bories, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 2 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 6 | |
| 16 | 2012 | 56 | |
| 17 | 2003 | 48 | |
| 18 | 2001 | 6 | |
| 19 | 2001 | 24 | |
| 20 | 2000 | 21 |
About Pierre Bories
Pierre Bories is a scholar working on Hematology, Applied Microbiology and Biotechnology and Genetics, having authored 60 papers that have together received 650 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Acute Myeloid Leukemia Research (14 papers), CAR-T cell therapy research (9 papers), Protein Degradation and Inhibitors (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Peptidase Inhibition and Analysis (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (193 citations), Nephrology (99 citations) and Genetics (72 citations). Pierre Bories has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Marie‐Pierre Ledoux, Raoul Herbrecht, Valérie Letscher‐Bru, D. Durand, Christian Récher, Lionel Rostaing, Sarah Bertoli, Nassim Kamar, Françoise Huguet and Audrey Sarry. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.